NCT00581282

Brief Summary

This study evaluates theories regarding cocaine abstinence which propose that increased presynaptic and postsynaptic dopamine activity and increased serotonin activity are associated with abstinence in cocaine dependent subjects at the beginning and three to six months after a treatment program. We are using positron emission tomography (PET), Magnetic Resonance Imaging (MRI) and diffusion tensor imaging (DTI) in cortical and subcortical areas in a series of brain imaging studies testing these theories of abnormalities in the dopamine and serotonin system for cocaine addiction by examining the distribution of 18F-fallypride, 18F-altanserin, and FDG. We are evaluating genetic theories associated with cocaine addiction through the examination of genetic markers and functional genomics.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2005

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

December 21, 2007

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 27, 2007

Completed
Last Updated

January 25, 2021

Status Verified

January 1, 2021

Enrollment Period

Same day

First QC Date

December 21, 2007

Last Update Submit

January 22, 2021

Conditions

Keywords

Cocaine abstinencePET scan

Outcome Measures

Primary Outcomes (1)

  • PET scans, fMRI scans

    The beginning and three to six months after a treatment program

Study Arms (2)

1

Cocaine abstinent group

Radiation: PET scanOther: fMRI

2

Normal healthy control group

Radiation: PET scanOther: fMRI

Interventions

PET scanRADIATION

positron emission tomography PET scan

12
fMRIOTHER

functional magnetic resonance imaging fMRI

12

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants in cocaine dependency treatment program Normal Healthy Control Subjects

You may qualify if:

  • Subjects must be male or female and English speaking.
  • Subjects must be adults with a history of diagnosis of cocaine dependence disorder (n=20) who are under supervised treatment for dependence or normal control (n=10).
  • Subjects must be between 21 to 65 years of age.

You may not qualify if:

  • Suicidality or psychosis.
  • Head injury, kidney or bladder disease or any unstable or serious medical conditions.
  • Prior exposure to radiation (including diagnostic or treatment x-rays), which might cause subjects to exceed standard guidelines.
  • Unwillingness or inability to adhere to the requirements of the study.
  • Donation or large loss of blood (\>400 ml) within the past month.
  • Current or very recent illnesses, painful conditions or other disorders, which in the judgment of the investigators, might invalidate the scientific goals of the study or pose undesirable difficulties or risks for subjects.
  • Pregnancy or breast feeding.
  • Individuals who would be unable to undergo a magnetic resonance imaging (MRI) scan, for example, individuals who suffer from claustrophobia, or who have metal clips in their body, metallic prostheses (i.e., replacement body parts, such as a hip joint), a pacemaker, or other pieces of metal in their body (shrapnel, metal filings, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Irvine, Brain Imaging Center

Irvine, California, 92697, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Joseph C Wu, M.D.

    University of California, Irvine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2007

First Posted

December 27, 2007

Study Start

December 1, 2005

Primary Completion

December 1, 2005

Study Completion

December 1, 2005

Last Updated

January 25, 2021

Record last verified: 2021-01

Locations